Table 4 is a hypothetical scenario of the number of cases that would be correctly diagnosed/excluded by the biomarkers at CRP and IP-10 cut offs when applied to a population of 1000 participants and with a TB prevalence of 21%. This evidence concerns the gene CRP and tuberculosis.